GRI Bio, Inc. (GRI)
2.33
+0.08
(+3.56%)
USD |
NASDAQ |
Feb 13, 16:00
2.29
-0.04
(-1.72%)
After-Hours: 20:00
GRI Bio EPS Diluted (Quarterly) : -5.343 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AIM ImmunoTech, Inc. | -1.567 |
| Ekso Bionics Holdings, Inc. | -0.5432 |
| Akari Therapeutics Plc | -0.1948 |
| Moleculin Biotech, Inc. | -17.02 |
| Autonomix Medical, Inc. | -0.3641 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.659M |
| Total Expenses (Quarterly) | 2.659M |
| Enterprise Value | -4.907M |
| Earnings Yield | -3.59K% |
| Normalized Earnings Yield | -3593.92 |